instrumentation analytical services oem applications consultancy partnerships

Commercial strategy

deltaDOT's aim is to provide revolutionary new instruments and kit based solutions to increase analytical performance and productivity in the life science, diagnostics, chemical analysis and biodefence markets.

The commercial strategy can be summarised as follows:
  • Direct sales and distributor network
  • OEM agreements
  • Partnerships to develop new instruments and applications

deltaDOT's commercial focus is aimed at the molecular biology, proteomic, analytical and QA/QC departments of major pharmaceutical and biotechnology businesses, where our instruments are finding immediate application.

By working with leading pharmaceutical, biotechnology, diagnostic, forensic, government and academic institutions, deltaDOT are ensuring that their novel products address market needs.

Label Free Process Analytical Technology

deltaDOT applies molecular biology and particle physics technology to the needs of biomolecular separation, including protein, DNA and RNA analysis.

The company has a strong proprietary position and extensive expertise in instrumentation, molecular biology, microfluidics, automation, computing and analysis which will contribute to improvements in knowledge, profitability and process time throughout drug discovery and general life sciences research.